Shares In Value reposted this
🚨 𝗡𝗲𝘄 𝗖𝗼𝘃𝗲𝗿𝗮𝗴𝗲: (𝗔𝗦𝗫: 𝗣𝗜𝗤) | 𝗣𝗿𝗼𝘁𝗲𝗼𝗺𝗶𝗰𝘀 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝗶𝗲𝘀 𝗟𝘁𝗱. 🚨 We're excited to initiate coverage on Proteomics International Laboratories (ASX: PIQ), a biotech company commercializing cutting-edge diagnostic tests. We've assigned a fair valuation of 𝗔$𝟮.𝟴𝟰, representing a 𝟯𝟯𝟭% 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝘂𝗽𝘀𝗶𝗱𝗲 from the current price of A$0.66. Our valuation is based on a 𝗵𝗶𝗴𝗵𝗹𝘆 𝗰𝗼𝗻𝘀𝗲𝗿𝘃𝗮𝘁𝗶𝘃𝗲 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵, factoring in cautious assumptions on market penetration. With its proprietary Promarker™ platform, PIQ is leading the way in diagnostics by identifying protein "fingerprints" in blood to detect diseases early. Key milestones ahead: - 𝗣𝗿𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝗗 (diabetes) targeting US commercial launch in H1 CY25 - 𝗣𝗿𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝗗 and 𝗣𝗿𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝗘𝘀𝗼 (esophageal cancer) set for Australian release This is an exciting time for PIQ with immense growth potential! 📈 👉 𝗥𝗲𝗮𝗱 𝗼𝘂𝗿 𝗱𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝟯𝟴-𝗽𝗮𝗴𝗲 𝗿𝗲𝗽𝗼𝗿𝘁: https://lnkd.in/ggdBxfNS Disclaimer: Report was posted on 8 October 2024 Richard Lipscombe James Williams Paul House Roger Moore Jacqueline Gray #biotech #diagnostics #ASX #PIQ #healthcare #investing